- Interaction Discovery
- Target Deconvolution
- Our libraries
- Our references
- Resource center
Evry, France - October 16, 2019
Please note that Hybrigenics Services (www.hybrigenics-services.com) and Hybrigenics Pharma (www.hybrigenics.com) have been two financially independent companies since January 2017 despite keeping similar names. Our activities are completely distinct and our operations entirely separate.
Hybrigenics Pharma announced on October 23, 2018 that the clinical development of its only drug candidate was discontinued for lack of efficacy. The winding-up of the company was suspended in January, 2019 when Hybrigenics Pharma received a takeover offer. On October 15, 2019 Hybrigenics Pharma announced its takeover by DMS Group with immediate effect.
None of this affects Hybrigenics Services in any way, nor the research we conduct for our clients and partners. We regret the confusion this might cause.
We thank investigators and companies across the world for their trust and continued interest in our services.